You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

EVZIO Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Evzio patents expire, and what generic alternatives are available?

Evzio is a drug marketed by Kaleo Inc and is included in two NDAs. There are thirty-four patents protecting this drug.

This drug has one hundred and forty-three patent family members in fifteen countries.

The generic ingredient in EVZIO is naloxone hydrochloride. There are twelve drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Evzio

A generic version of EVZIO was approved as naloxone hydrochloride by HOSPIRA on September 24^th, 1986.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for EVZIO?
What are the global sales for EVZIO?
What is Average Wholesale Price for EVZIO?

Summary for EVZIO

International Patents:	143
US Patents:	33
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	56
Patent Applications:	1,704
Drug Prices:	Drug price information for EVZIO
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for EVZIO
What excipients (inactive ingredients) are in EVZIO?	EVZIO excipients list
DailyMed Link:	EVZIO at DailyMed

Drug patent expirations by year for EVZIO

Drug Prices for EVZIO

US Patents and Regulatory Information for EVZIO

EVZIO is protected by thirty-three US patents.

Patents protecting EVZIO

Ultrafiltration membrane and a preparation method thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO DELIVER A DOSE OF NALOXONE

Devices and methods for delivering opioid antagonists including formulations for naloxone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO DELIVER A BIOEQUIVALENT DOSE OF A NALOXONE COMPOSITION VIA A NEEDLE

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems, and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device configured to produce an audible output
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medical injector with compliance tracking and monitoring
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device having an electronic circuit system
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems, and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device having an electronic circuit system
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Medicament delivery device for administration of opioid antagonists including formulations for naloxone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE OF A DELIVERY DEVICE TO ADMINISTER A DOSE OF NALOXONE

Devices and methods for delivering opioid antagonists including formulations for naloxone
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE OF AN AUTO INJECTOR TO ADMINISTER NALOXONE HCL

Devices, systems, and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR CONFIRMING DOSE DELIVERY

Devices, systems and methods for medicament delivery
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Kaleo Inc	EVZIO (AUTOINJECTOR)	naloxone hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	209862-001	Oct 19, 2016		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Kaleo Inc	EVZIO	naloxone hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	205787-001	Apr 3, 2014		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Kaleo Inc	EVZIO (AUTOINJECTOR)	naloxone hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	209862-001	Oct 19, 2016		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for EVZIO

See the table below for patents covering EVZIO around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	2008528210		⤷ Sign Up
World Intellectual Property Organization (WIPO)	2006083876		⤷ Sign Up
China	103491999	Devices and methods for delivering medicaments from a multi-chamber container	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for EVZIO

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1685839	92292	Luxembourg	⤷ Sign Up	PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.